Because doses of antihypertensive agents necessary to control human arterial hypertension at relatively normotensive levels were observed to decrease with time, records of all patients in our series receiving oral hexamethonium chloride and hydralazine (but no other drugs) were analyzed (114 cases). After two years of therapy, those patients maintaining average diastolic pressures below 100 mm. Hg were found to require considerably less methonium ion while those unable or unwilling to control their pressures to this degree needed approximately their initial doses. Further decreases in drug requirements for the well-controlled group occurred after three years. Ten were able to discontinue all medication eventually and nine others needed only smaller doses of hydralazine; in these reversal of secondary changes was sometimes observed. Prolonged, continuous and adequate drug therapy is apparently associated with a change in the basic process producing hypertension.
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FTER the first consistent successes in
A chronically lowering markedly ele117k vated human diastolic pressure to normal or nearly normal values by autonomic blockade plus oral hydralazine," 2 interest was aroused as to the permanence of the change or lack of it. Although the side effects of therapy gradually dwindled in a manner reminiscent of the tolerance characteristic for methonium compounds,3 no tolerance to the antihypertensive effect of the combined treatment has been observed after four years. On the contrary, a progressive diminution in drug requirement has frequently been observed.' Moreover, after varying periods of induced normotension, some patients, including an occasional one who originally had severe diastolic hypertension, have been gradually able to diminish and eventually to discontinue treatment entirely, without reelevation of blood pressure. To ascertain the magnitude of such trends, the dosage and blood pressure data for our patients orally treated with hydralazine and hexamethonium chloride have been tabulated. This paper ill- heart failure, cerebrovascular accident, coronary occlusion or renal functional impairment. Forty patients were in the so-called mild group with control diastolic pressures from 100 through 114 mm.; 41 were in the moderate group with pressures from 115 through 129 mm. and 33 were in the severe group with pressures from 130 through 180 mm. Hg.* The average pretreatment systolic pressures at rest for the three groups was 221, 193, and 179 mm. Hg respectively. A posttherapeutic diastolic pressure of 100 mm. Hg was arbitrarily chosen to divide each of the three groups into a so-called controlled and an uncontrolled subgroup. These pressures were calculated for the pair of weeks, exactly one month and one year after hospital discharge;t when they were * For the sake of simplicity throughout the paper the italicized terms mild, moderate, and severe each designates a group of patients as defined in the text solely by their pretreatment diastolic pressures. This grouping is not to be confused with that previously used.2 Of the patients here discussed nine had "moderate benign'" stages of hypertension by the more usual classification, 66 had "severe benign" stages and 39 had "malignant" or "premalignant" stages, the latter with resting diastolic pressures above 120 mm. Hg and normal optic discs but with hemorrhagic and/or exudative retinitis and gravely impaired renal function. Similarly the italicized terms controlled and uncontrolled designates the subgroups of patients as defined in the text solely by their posttherapeutic diastolic pressure. For simplicity's sake in comparing values of both blood pressure and dosages, the period beginning one month after hospital discharge will several times be indicated as the initial posttreatment period to distinguish it from the periods beginning 1, 2 or 3 years following discharge.
t The blood pressure and the dosage of medication immediately before hospital discharge is an unfair base of comparison for the follow-up data since the period of control is brief and often does not represent a steady state. Diastolic pressure and drug intake for the last 48 hours in the hospital, for the first week at home and for the pair of seven day periods beginning exactly one and two months after discharge were calculated for a considerable number of patients. The first two were different from each other and from the last two, which, on the other hand, were quite similar. Using a fortnight instead of a week was carefully checked and found to be no more reliable; seldom was the variation between two consecutive weeks more than 10 per cent with respect either to blood pressure or drug intake. On this basis, the seven-day period, exactly one month following discharge from the hospital, was used to obtain the initial posttreatment blood pressure and dosage levels. Since warm weather lowers both the blood pressure and the hexamethonium requirement, only yearly follow-ups obviated seasonal bias and hence were considered worthwhile. Table 3 gives the individual data for those who were able gradually to decrease their doses of autonomic blocking agent and finally discontinue it while still maintaining an essentially normal diastolic pressure. Of the 19 patients, 10 had discontinued their hydralazine as wvell at the month indicated. All in the severe group had originally had electrocardiographic abnormalities, most had had albuminuria and half had had hemorrhagic retinitis. Considerable electrocardiographic evidence of disease, but few of the other changes beyond elevated diastolic pressure, had been present in the other two groups.
fight patients of the 114 in the series died after an average of 26 months from the beginning of therapy. Three were not controlled, one year after starting treatment, because of intermittent discontinuation or insufficient dosage. In the other five the diastolic pressure had remained below 100 mim. Hg for a year; however, in 2 at least and probably in 2 others, therapy was lessened to the point of a reelevation of blood pressure before death. A cerebrovascular accident was the terminal event in six. One died of cardiac rupture after myocardial infarction. The other, who had had a pretreatment diastolic pressure of 176 mm. Hg; hemorrhagic and exudative retinitis with edema of the optic nerves, and azotemia, died of renal failure after 30 months of treatment.* The problem of patients passing from a controlled to an uncontrolled subgroup wvas never encountered in analyzing a patient's 1.1 Table 3 gives detailed data on 19 patients who without compromising their normotension have been able in periods from 12 to 39 months to diminish gradually and eventually discontinue the blocking agent (hexamethonium chloride, C6) which was initially found necessary to control their hypertension. Four had pretreatment diastolic pressures of 130 mm. Hg or higher; 6 had pressures from 115 to 129 and 9 had pressures below 115. The next to the last patient in the table had been sympathectomized prior to drug therapy, which may explain the low initial dosage of hexamethonium chloride and the relatively high diastolic pressure at 30 months. Ten of these patients have been able to discontinue completely their hydralazine. The first column indicates the average daily dose of hexamethonium after a month at home in the manner of table 1 and the text. The second column lists the number of months at which methonium medication was automatically terminated and the third indicates the dose of hydralazine at that time. The next five pairs of columns tabulate the control values and the values at the end of discontinuation of methonium for five laboratory evidences of the severity of hypertension. The pretreatment diastolic pressure is the previously discussed mean. The sixth and seventh columns show when hemorrhages (h) and/or exudates (e) were present in the optic fundi; the next pair, the presence or absence of albuminuria; the next pair, the 15-minute excretion of intravenously injected phenol red when the urine volume was at least 50 cc; and the final pair, electrocardiographic interpreta- 
